Search Results 381-390 of 16656 for ������������KA���:ZA31���24������ ���������������������������������

  1. Tumor Shrinking Nanoparticle used to Fight Cancer and Brain Tumors - Mayo Clinic

    ... . VID-20440754. Home; Tumor Shrinking Nanoparticle used to Fight Cancer and Brain Tumors. Final days of 5X Challenge!

  2. Publications - Brad S. Karon, M.D., Ph.D. - Mayo Clinic

    2024 Jul; 99 (7):1091-1100 Epub 2024 Apr 24 ... Tange JI, Grill D, Koch CD, Ybabez RJ, Krekelberg BJ, Fylling KA ... Epub 2012 Oct 24. View PubMed; Wickremasinghe ...

  3. Paraneoplastic syndromes of the nervous system - Doctors and departments - Mayo Clinic

    This group of conditions affects people who have cancer and occurs when parts of the immune system attack parts of the nervous system.

  4. Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors - Mayo Clinic

    Pazopanib hydrochloride may prevent the growth of new blood vessels that tumors need to grow. Studying samples of blood in the laboratory from patients ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  6. Digital Platform for Remote Monitoring of COPD After Bronchoscopic Lung Volume Reduction - Mayo Clinic

    Rochester, Minnesota: 24-001021; Jacksonville, Florida: 24-001021. About this study. The purpose of this study is to determine if remote monitoring using the ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Publications - Vinayak Nagaraja, M.B.B.S. - Mayo Clinic

    2015 Jul; 24 (7):660-6 Epub 2015 Feb 09. View PubMed; Back L, Nagaraja V, Kapur A, Eslick GD. Role of decompressive hemicraniectomy in extensive middle ...

  9. Publications - Taxiarchis Kourelis, M.D. - Mayo Clinic

    Clin Lymphoma Myeloma Leuk. 2024 Oct; 24(10):e329-e335. Epub 2024 Jun 01. View PubMed; Khurana A, Rosenthal AC, Mohty R, Gaddam ...

  10. A Trial of the Effectiveness, Safety, and Tolerability of a Single Oral Administration of CP101 for the Prevention of Recurrent Clostridioides difficile Infection (PRISM4) - Mayo Clinic

    ... 24 visit. Males (as assigned at birth) must fulfill the following criteria ... difficile-related diarrhea within 8 weeks after receiving CP101 or placebo in Part ...